What This Fund’s Million Exit Signals Fresh Investor Cues
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
Wondering which is better: cash back or points credit card? Explore the pros and cons to choose the right card for your needs.
27,103 articlesA major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
As quantum dreams grow from labs to law and logistics, Rigetti's domestic footprint and government ties could propel ...
Block announces 4,000 layoffs, about 46% of its workforce, as it accelerates an AI-first transformation. CFO Amrita A...
The AI boom isn’t a one-stock story. Here are three well-positioned names beyond Nvidia that could fuel the next rall...
A nation that stays forever young isn’t about youth alone—it’s about mindset. This article translates timeless quotes...
Rheinmetall posted a quarterly miss that undercut expectations for revenue, net income and margins, triggering a pull...
A public clash over strategy and governance wrapped up for now, but 2026 could be a real test for lululemon. This inv...
Insider stock moves can be alarming, but they aren’t always a red flag. This guide explains how to read a fastly stoc...
Snowflake posted a record quarter, but its stock trades far from its peak as investors weigh whether AI-driven growth...
Volatility kept markets unsettled this week. Advisers say the right move depends on timelines and cash needs, with ma...
Meta Platforms stock crushed the market today as Meta rolled out a business-focused AI tool worldwide. Investors weig...
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...